| 7350 |
Okinawa Financial Group, Inc.
|
Personnel |
|
Notice Regarding Changes to Representative Directors and Officers at the Company and Its Subsidiaries
|
Mar 6, 2026
|
| 7279 |
Hirlex Corporation
|
Other |
|
Notice Regarding Change of Trade Name of Consolidated Subsidiaries
|
Mar 6, 2026
|
| 7279 |
Hilex Corporation
|
M&A |
|
Notice Regarding Change of Reporting Segments
|
Mar 6, 2026
|
| 7279 |
Hirlex Corporation
|
Earnings |
|
Financial Summary for the First Quarter of the Fiscal Year Ending October 2026 (Japanese GAAP) (Consolidated)
|
Mar 6, 2026
|
| 7279 |
Hilex Corporation
|
Earnings |
|
Notice Regarding Revision of Consolidated Earnings Guidance for the Second Quarter (Interim) and Full Fiscal Year Ending October 2026
|
Mar 6, 2026
|
| 7279 |
Hirlex Corporation
|
Earnings |
|
Notice on Recording Special Profit (Gain on Negative Goodwill)
|
Mar 6, 2026
|
| 2602 |
Nisshin OilliO Group, Ltd.
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition
|
Mar 6, 2026
|
| 1802 |
Obayashi Corporation
|
Personnel |
|
Notice Regarding Changes of Representative Director and Officers
|
Mar 6, 2026
|
| 9832 |
Autobacs Seven Co., Ltd.
|
Earnings |
|
Notice Regarding the February Monthly Sales Overview (Preliminary) for the Fiscal Year Ending March 2026
|
Mar 6, 2026
|
| 3116 |
Toyota Boshoku Corporation
|
Other |
|
Regarding Market Recall Measures for Vehicles Equipped with Our Group’s Products
|
Mar 6, 2026
|
| 9532 |
Osaka Gas Co., Ltd.
|
Share Buyback |
|
Notice Regarding Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Mar 6, 2026
|
| 9039 |
Sakai Moving Service Co., Ltd.
|
Other |
|
Notice Regarding Partial Changes (Enhancement) to the Shareholder Benefit Program
|
Mar 6, 2026
|
| 9039 |
Sakai Moving Service Co., Ltd.
|
Earnings |
|
Announcement Regarding February 2026 Monthly Sales (Preliminary Figures)
|
Mar 6, 2026
|
| 4894 |
Quolips, Inc.
|
Strategy |
|
Acquisition of Conditional and Time-limited Manufacturing and Marketing Approval for Human (Allogeneic) iPS Cell-Derived Cardiomyocyte Sheet
|
Mar 6, 2026
|
| 3663 |
Celsys, Inc.
|
Earnings |
|
Announcement of Monthly Business Progress Report for February 2026
|
Mar 6, 2026
|
| 9663 |
Nagowa Co., Ltd.
|
Share Buyback |
|
Notice Regarding the Result of Treasury Stock Acquisition through ToSTNeT-3 and Completion of Treasury Stock Acquisition
|
Mar 6, 2026
|
| 6859 |
ESPEC Corporation
|
Share Buyback |
|
Notice Regarding the Status of Treasury Stock Acquisition (Acquisition of Treasury Stock Based on Provisions of Article 165, Paragraph 2 of the Companies Act)
|
Mar 6, 2026
|
| 4506 |
Sumitomo Pharma Co., Ltd.
|
Strategy |
|
Announcement Regarding the Obtaining of Manufacturing and Marketing Approval in Japan for Allogeneic iPS Cell-Derived Dopaminergic Neural Progenitor Cell ‘Amsepre®’
|
Mar 6, 2026
|
| 4005 |
Sumitomo Chemical Company, Limited
|
Strategy |
|
Notice Regarding Approval for Manufacturing and Marketing of iPS Cell-Derived Product “Amshepli®” for Parkinson’s Disease Patients by Our Subsidiary
|
Mar 6, 2026
|
| 7860 |
Avex Inc.
|
M&A |
|
Notice Regarding Absorption-Type Merger (Simplified Merger) of a Wholly-Owned Subsidiary
|
Mar 5, 2026
|
